|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hearing Loss, Sensorineural | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Deafness | |||||
| Hearing Loss | |||||
| 3 | More general conditions related to this trial | ||||
| Ear Diseases | |||||
| Hearing Disorders | |||||
| Nervous System Diseases | |||||
| Neurologic Manifestations | |||||
| Otorhinolaryngologic Diseases | |||||
| Sensation Disorders | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| Corticosteroids | |||||
| Methotrexate | |||||
| 5 | More general drug interventions related to this trial | ||||
| Abortifacient Agents | |||||
| Abortifacient Agents, Nonsteroidal | |||||
| Antimetabolites | |||||
| Antimetabolites, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Antirheumatic Agents | |||||
| Dermatologic Agents | |||||
| Enzyme Inhibitors | |||||
| Folic Acid Antagonists | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Nucleic Acid Synthesis Inhibitors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Reproductive Control Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute on Deafness and Other Communication Disorders (NIDCD) | |||||